1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide

Impurity

This molecule is a impurity of Linagliptin.

1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide

In Stock

Impurity

1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide

Cat. No. ANTPRD8973CAS 2074688-82-5In Stock

Technical Data

Cat. No.ANTPRD8973

CAS2074688-82-5

Mol. FormulaC₅₈H₅₈N₁₆O₆

Mol. Weight1075.208 g/mol

IUPAC1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide

SMILESCC#CCn1c(N2CCC[C@@H](NC(=O)c3ccccc3C(=O)N[C@@H]3CCCN(c4nc5c(c(=O)n(Cc6nc(C)c7ccccc7n6)c(=O)n5C)n4CC#CC)C3)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C

InChIInChI=1S/C58H58N16O6/c1-7-9-29-71-47-49(67(5)57(79)73(53(47)77)33-45-59-35(3)39-21-13-15-25-43(39)63-45)65-55(71)69-27-17-19-37(31-69)61-51(75)41-23-11-12-24-42(41)52(76)62-38-20-18-28-70(32-38)56-66-50-48(72(56)30-10-8-2)54(78)74(58(80)68(50)6)34-46-60-36(4)40-22-14-16-26-44(40)64-46/h11-16,21-26,37-38H,17-20,27-34H2,1-6H3,(H,61,75)(H,62,76)/t37-,38-/m1/s1

InChI KeyMEGABANPJKPREU-XPSQVAKYSA-N

Description

Overview

1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide, Linagliptin, 2074688-82-5, 1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide

Anant Labs is the renowned and Authentic Manufacturer and Supplier of 1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide in India.

At Anant, we have expertise in synthetic organic chemistry and pharmaceutical analysis and we provide cost effective and accurate custom research services to the industry.

Synonyms

N1,N2-Bis[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-1,2-benzenedicarboxamideLinagliptin Impurity 44Linagliptin Impurity WN1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide1,2-Benzenedicarboxamide, N1,N2-bis[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-